Investors find safety in J&J shares, but run could stall

NEW YORK, April 14 (Reuters) - After lagging a six-year healthcare sector run fueled by fast-growing biotech companies, Johnson & Johnson shares have beaten the group in 2016 as investors turn to safety in rocky equity markets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.